See also this year's filing and all EDGAR filings for this company.
PDF Report 0001386570_2021_Niagen_Bioscience_Inc.pdf
Logs
Graph
Absolute values for 0001386570, Niagen Bioscience Inc
| xvar | xval | |
|---|---|---|
| 0 | LiabilitiesNoncurrent | 997,000 |
| 1 | LiabilitiesCurrent | 16,476,000 |
| 2 | remainder_Liabilities | 4,461,000 |
| 3 | AssetsCurrent | 32,219,000 |
| 4 | AssetsNoncurrent | 1,851,000 |
| 5 | PropertyPlantAndEquipmentNet | 3,206,000 |
| 6 | Goodwill | 1,082,000 |
| 7 | remainder_Assets | 0 |
| 8 | GeneralAndAdministrativeExpense | 75,379,000 |
| 9 | ResearchAndDevelopmentExpense | 3,732,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 59,257,000 |
| 12 | remainder_NetIncome | -71,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Liabilities | 21,934,000 |
| 1 | Assets | 38,358,000 |
| 2 | Expenses | 79,111,000 |
| 3 | Revenues | 59,257,000 |
| 4 | StockholdersEquity | 16,424,000 |
| 5 | NetIncome | -19,925,000 |
| 6 | ComprehensiveNetIncome | -19,925,000 |
| 7 | BaseVar | 99,365,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.0854 |
| 9 | EconomicCapitalRatio | 0.930 |